Size and morphology of toxic oligomers of amyloidogenic proteins: a case study of human stefin B

References

• Dobson C M. Getting out of shape. Nature 2002; 418: 729–730
   PubMed Web of Science ®Google Scholar
• Walsh D M, Selkoe D J. Oligomers on the brain: the emerging role of soluble protein aggregates in neurodegeneration. Protein Pept Lett 2004; 11: 213–228
   PubMed Web of Science ®Google Scholar
• Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson C M, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 2002; 416: 507–511
   PubMed Web of Science ®Google Scholar
• Bucciantini M, Calloni G, Chiti F, Formigli L, Nosi D, Dobson C M, Stefani M. Prefibrillar amyloid protein aggregates share common features of cytotoxicity. J Biol Chem 2004; 279: 31374–31382
   PubMed Web of Science ®Google Scholar
• Kayed R, Head E, Thompson J L, McIntire T M, Milton S C, Cotman C W, Glabe C G. Common structure of soluble amyloid oligomers implies common pathology. Science 2003; 300: 487–489
   Google Scholar
• Marx F P, Holzmann C, Strauss K M, Li L, Eberhardt O, Gerhardt E, Cookson M R, Hernandez D, Farrer M J, Kachergus J, Engelender S, Ross C A, Berger K, Schols L, Schulz J B, Riess O, Kruger R. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease. Hum Mol Genet 2003; 12: 1223–1231
   PubMed Web of Science ®Google Scholar
• Tucker H M, Rydel R E, Wright S, Estus S. Human amylin induces “apoptotic” pattern of gene expression concomitant with cortical neuronal apoptosis. J Neurochem 1998; 71: 506–516
   PubMed Web of Science ®Google Scholar
• Bucciantini M, Rigacci S, Berti A, Pieri L, Cecchi C, Nosi D, Formigli L, Chiti F,Stefani M. Patterns of cell death triggered in two different cell lines by HypF-N prefibrillar aggregates. FASEB J 2005; 19: 437–439
   PubMedGoogle Scholar
• Lashuel H A, Hartley D, Petre B M, Walz T, Lansbury P T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002; 418: 291
   PubMed Web of Science ®Google Scholar
• Kagan B L, Hirakura Y, Azimov R, Azimova R, Lin M C. The channel hypothesis of Alzheimer's disease: current status. Peptides 2002; 23: 1311–1315
   PubMed Web of Science ®Google Scholar
• Gorbenko G P, Kinnunen P KJ. The role of lipid-protein interactions in amyloid-type protein fibril formation. Chem Phys Lipids 2006; 141: 72–82
   PubMed Web of Science ®Google Scholar
• Arispe N, Pollard H B, Rojas E. β-Amyloid Ca2+-channel hypothesis for neuronal death in AD. Mol Cell Biochem 1994; 140: 129–135
   Google Scholar
• Yip C M, Elton E A, Darabie A A, Morrison M R, McLaurin J. Cholesterol, a modulator of membrane-associated A-beta-fibrillogenesis and neurotoxicity. J Mol Biol 2001; 311: 723–734
   PubMed Web of Science ®Google Scholar
• Anderluh G, Gutierrez-Aguirre I, Rabzelj S, Čeru S, Kopitar-Jerala N, Maček P, Turk V, Žerovnik E. Interaction of human stefin B in the prefibrillar oligomeric form with membranes – correlation with cellular toxicity. FEBS J 2005; 272: 3042–3051
   PubMed Web of Science ®Google Scholar
• Cleary J P, Walsh D M, Hofmeister J J, Shankar G M, Kuskowski M A, Selkoe D J, Ashe K H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 2005; 8: 79–84
   PubMed Web of Science ®Google Scholar
• Žerovnik E, Pompe-Novak M, Škarabot M, Ravnikar M, Muševič I, Turk V. Human stefin B readily forms amyloid fibrils in vitro. Biochim Biophys Acta 2002a; 1594: 1–5
   PubMedGoogle Scholar
• Žerovnik E, Zavašnik-Bergant V, Kopitar-Jerala N, Pompe-Novak M, Škarabot M, Goldie K, Ravnikar M, Muševič I, Turk V. Amyloid fibril formation by human stefin B in vitro: immunogold labelling and comparison to stefin A. Biol Chem 2002b; 383: 859–863
   PubMed Web of Science ®Google Scholar
• Žerovnik E, Turk V, Waltho J P. Amyloid fibril formation by human stefin B: influence of the initial pH-induced intermediate state. Biochem Soc Trans 2002c; 30: 543–547
   PubMed Web of Science ®Google Scholar
• Jenko S, Škarabot M, Kenig M, Gunčar G, Muševič I, Turk D, Žerovnik E. Different propensity to form amyloid fibrils by two homologous proteins – human stefins A and B: searching for an explanation. Proteins: Structure, Function and Bioinformatics 2004; 55: 417–425
   PubMed Web of Science ®Google Scholar
• Matsunaga Y, Žerovnik E, Yamada T, Turk V. Conformational changes preceding amyloid-fibril formation of amyloid-beta and stefin B; parallels in pH dependence. Curr Med Chem 2002; 9: 1717–1724
   PubMed Web of Science ®Google Scholar
• Brzin J, Kopitar M, Turk V, Machleidt W. Protein inhibitors of cysteine proteinases. I. Isolation and characterization of stefin, a cytosolic protein inhibitor of cysteine proteinases from human polymorphonuclear granulocytes. Hoppe Seylers Z Physiol Chem 1983; 364: 1475–1480
   PubMedGoogle Scholar
• Turk V, Bode W. The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett 1991; 285: 213–219
   PubMed Web of Science ®Google Scholar
• Rawlings N D, Tolle D P, Barrett A J. MEROPS: the peptidase database. Nucleic Acids Res 2004; 32: D160–164
   PubMed Web of Science ®Google Scholar
• Maruyama K, Kametani F, Ikeda S, Ishihara T, Yanagisawa N. Characterization of amyloid fibril protein from a case of cerebral amyloid angiopathy showing immunohistochemical reactivity for both beta protein and cystatin C. Neurosci Lett 1992; 144: 38–42
   PubMed Web of Science ®Google Scholar
• Sastre M, Calero M, Pawlik M, Mathews P M, Kumar A, Danilov V, Schmidt S D, Nixon R A, Frangione B, Levy E. Binding of cystatin C to Alzheimer's amyloid beta inhibits in vitro amyloid fibril formation. Neurobiol Aging 2004; 25: 1033–1043
   PubMed Web of Science ®Google Scholar
• Jensson O, Palsdottir A, Thorsteinsson L, Arnason A, Abrahamson M, Olafsson I, Grubb A. Cystatin C mutation causing amyloid angiopathy and brain hemorrhage. Biol Chem Hoppe Seyler 1990; 371: 229–232
   PubMed Web of Science ®Google Scholar
• Ii K, Ito H, Kominami E, Hirano A. Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged. Virchows Archiv A Pathol Anat 1993; 423: 185–194
   Google Scholar
• Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson A, Jaskolski M. Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping. Nat Struct Biol 2001; 8: 316–320
   PubMedGoogle Scholar
• Staniforth R A, Giannini S, Higgins L D, Conroy M J, Hounslow A M, Jerala R, Craven C J, Waltho J P. Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J 2001; 20: 4774–4781
   PubMed Web of Science ®Google Scholar
• Jenko Kokalj S, Gunčar G, Stern I, Morgan G, Rabzelj S, Kenig M, Staniforth R A, Waltho J P, Žerovnik E, Turk D. Essential role of proline isomerization in stefin B tetramer formation. J Mol Biol 2007; 366: 1569–1579
   PubMed Web of Science ®Google Scholar
• Kenig M, Berbić S, Kriještorac A, Kroon-Žitko L, Tušek M, Pompe-Novak M, Žerovnik E. Differences in aggregation properties of three site-specific mutants of recombinant human stefin B. Prot Sci 2004; 13: 63–70
   Google Scholar
• Rabzelj S, Turk V, Žerovnik E. In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1. Prot Sci 2005; 14: 2713–2722
   PubMed Web of Science ®Google Scholar
• Wogulis M, Wright S, Cunningham D, Chilcote T, Powell K, Rydel R E. Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J Neurosci 2005; 25: 1071–1080
   PubMed Web of Science ®Google Scholar
• Cirman T, Orešić K, Mazovec G D, Turk V, Reed J C, Myers R M, Salvesen G S, Turk B. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004; 279: 3578–3587
   PubMed Web of Science ®Google Scholar
• Garcia-Calvo M, Peterson E P, Rasper D M, Vaillancourt J P, Zamboni R, Nicholson D W, Thornberry N A. Purification and catalytic properties of human caspase family members. Cell Death Differ 1999; 6: 362–369
   PubMed Web of Science ®Google Scholar
• Rabzelj S. Amyloid fibrillation and interaction with lipid membranes of human stefin B and chosen mutants in vitro. University of Ljubljana, Biotechnical Faculty, Ljubljana 2006, PhD thesis
   Google Scholar
• Hoshi M, Sato M, Matsumoto S, Noguchi A, Yasutake K, Yoshida N, Sato K. Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc Natl Acad Sci USA 2003; 100: 6370–6375
   PubMed Web of Science ®Google Scholar
• Klein W L. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 2002; 41: 345–352
   PubMed Web of Science ®Google Scholar
• Lambert M P, Klein W L. Diffusible, nonfibrillar ligands derived from A-beta 1-42 are potent central nervous system toxins. Proc Natl Acad Sci USA 1998; 95: 6448–6453
   PubMed Web of Science ®Google Scholar
• Green J D, Goldsbury C, Kistler J, Cooper G J, Aebi U. Human amylin oligomer growth and fibril elongation define two distinct phases in amyloid formation. J Biol Chem 2004; 279: 12206–12212
   Google Scholar
• Žerovnik E, Škarabot M, Škerget K, Giannini S, Stoka V, Jenko Kokalj S, Staniforth R A. Amyloid-fibril formation by human stefin B: influence of pH and TFE on fibril growth and morphology. Amyloid J Prot Folding Disord 2007; 14: 237–247
   PubMed Web of Science ®Google Scholar